What is the second most common site where the common bile duct (CBD) opens into the gastrointestinal tract?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Second Most Common Site of Common Bile Duct Opening in the Gastrointestinal Tract

The second most common site where the common bile duct (CBD) opens into the gastrointestinal tract is the duodenal bulb (first part of duodenum). 1

Normal Anatomy and Variations

  • The CBD normally opens at the ampulla of Vater in the second portion of the duodenum, which is the most common location 2
  • Ectopic openings of the CBD are rare congenital anomalies but have significant clinical implications 1
  • According to case series data, the distribution of ectopic CBD openings shows the duodenal bulb as the second most common site after the normal location 1

Distribution of Ectopic CBD Openings

  • First portion of duodenum (duodenal bulb): second most common site, accounting for approximately 36% of ectopic openings 1
  • Third portion of duodenum: third most common site 1
  • Stomach: rare site for ectopic CBD opening 1
  • Pancreatic duct: can occur in cases of double common bile duct 3, 4

Clinical Significance

  • Ectopic openings of the CBD are associated with higher rates of:

    • Choledocholithiasis (biliary stones) 1, 5
    • Cholangitis 1
    • Acute pancreatitis 1
    • Duodenal deformity or stenosis 5
  • The location of ectopic CBD openings has important implications for:

    • Surgical planning and potential complications 3
    • Endoscopic access and treatment approaches 5
    • Risk of associated malignancies 4

Diagnostic Considerations

  • Ectopic CBD openings may be suspected on transabdominal ultrasound but are typically confirmed by:

    • Endoscopic retrograde cholangiopancreatography (ERCP) 3, 1
    • Magnetic resonance cholangiopancreatography (MRCP) 6
  • Awareness of this anatomical variation is crucial for endoscopists and surgeons to avoid complications during procedures 3, 5

Treatment Implications

  • Endoscopic treatment is feasible in patients with ectopic CBD openings but may require multiple procedures 5
  • Surgical intervention may be necessary in cases where endoscopic management fails 5
  • Long-term follow-up is important due to the risk of recurrent biliary problems 5

Special Considerations

  • Double common bile duct (DCBD) is a rare anomaly where two common bile ducts exist, with one opening at the normal location and the other (accessory CBD) opening at an ectopic site 3, 4
  • The site of the accessory CBD opening has important implications for associated pathologies and treatment approaches 4
  • Middle-aged males with duodenal deformity/stenosis should be evaluated for possible ectopic CBD opening 5

Related Questions

What is the second most common site where the common bile duct (CBD) opens into the gastrointestinal tract?
What is the most appropriate initial investigation for an elderly man with progressive jaundice, deep yellow sclera, dark urine, pale stool, a distended gallbladder with stones, and a dilated common bile duct?
What is the next step in managing a patient with multiple gallstones and dilatation of the intrahepatic bile ducts (Intrahepatic Bile Ducts) after an abdominal Ultrasound (US)?
What is the diagnosis and management for a patient with cholelithiasis (gallstones) associated with signs of choledocholithiasis (common bile duct stones) and an anatomical variation where the anterior segmental bile duct drains into the common hepatic duct, caudal to the bifurcation of the posterior segmental bile duct and left main bile duct?
What is the recommended management for a patient with gallbladder microlithiases and a dilated common bile duct (CBD)?
What is the recommended increase in NPH (Neutral Protamine Hagedorn) insulin for a patient with increased tube feeding from 60 ml/hr to 90 ml/hr, currently receiving 68 units of NPH insulin?
What is the best treatment approach for an 81-year-old woman with recurrent E. coli urinary tract infection (UTI), previously treated with Nitrofurantoin (Macrobid), who had a negative urine culture 2 weeks ago?
How to manage hyponatremia and hypochloremia in a patient on chlorthalidone, amlodipine, and losartan with suspected dehydration?
Is Extracorporeal Shock Wave Lithotripsy (ESWL) the same as lithotripsy?
What is the management approach for a patient with Achilles pain, who is Antinuclear Antibody (ANA) positive with a titre of 1:80 and an elevated Erythrocyte Sedimentation Rate (ESR) of 39?
What is the starting dose of gabapentin (Gabapentin) for Parkinson's disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.